Drugs / Human Umbilical Mesenchymal Stem Cells
last change Jan 2026 re-read 3 minutes ago

Human Umbilical Mesenchymal Stem Cells

Cell therapy

Developed for
osteoarthritis, knee
Investigated by
First Affiliated Hospital of Wannan Medical College

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT06082440 Nov 2023 → Aug 2025 osteoarthritis, knee First Affiliated Hospital of Wannan Medical College Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Human Umbilical Mesenchymal Stem Cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT06082440 ↗
Modality Cell therapy “human umbilical cord mesenchymal stem cells” NCT06082440 ↗
Route Other “Ntra-articular injection inject a corresponding dose of cells suspension into each joint cavity according to the lesion site.” NCT06082440 ↗